Bronchopulmonary Dysplasia: Executive Summary of a Workshop

Overview

Journal J Pediatr

Specialty Pediatrics

Date 2018 Mar 20

PMID 29551318

Citations 325

Authors

Rosemary D Higgins

Alan H Jobe

Marion Koso-Thomas

Eduardo Bancalari

Rose M Viscardi

Tina V Hartert

Rita M Ryan

Suhas G Kallapur

Robin H Steinhorn

Girija G Konduri

Stephanie D Davis

Bernard Thebaud

Ronald I Clyman

Joseph M Collaco

Camilia R Martin

Jason C Woods

Neil N Finer

Tonse N K Raju

Affiliations

Soon will be listed here.

Citing Articles

Can prenatal conditions impact the effect of omega-3 on bronchopulmonary dysplasia in very preterm infants? A secondary analysis of a randomized controlled trial.

Rais H, Pronovost E, Guillot M, Boutin A, Simonyan D, Mohamed I Eur J Pediatr. 2025; 184(4):243.

PMID: 40072608 DOI: 10.1007/s00431-025-06053-4.

Safety and efficacy of proton pump inhibitors in preterm infants with gastroesophageal reflux disease.

King E, Horn D, Gluchowski N, OReilly D, Bruschettini M, Cooper C Cochrane Database Syst Rev. 2025; 3:CD015127.

PMID: 40066936 PMC: 11895421. DOI: 10.1002/14651858.CD015127.pub2.

Double-blind, non-inferiority, randomized controlled trial of dexamethasone 4, 5 and 6 mg for preventing adverse neonatal and maternal outcomes in very preterm to late preterm pregnancies between 29 and 36 weeks of gestation: study protocol.

Chawanpaiboon S, Wutthigate P, Anuwutnavin S, Sutchritpongsa S Reprod Health. 2025; 22(1):30.

PMID: 40025486 PMC: 11874782. DOI: 10.1186/s12978-025-01965-8.

Elimination of Sepsis and Reducing Several Morbidities in a Tertiary NICU in Greece After Changing Antibiotic, Ventilation, and Nutrition Protocols.

Dermitzaki N, Atzemoglou N, Giapros V, Baltogianni M, Rallis D, Gouvias T Antibiotics (Basel). 2025; 14(2).

PMID: 40001403 PMC: 11851818. DOI: 10.3390/antibiotics14020159.

Reducing prematurity-related neonatal mortality: a quality improvement project in Gandhi Memorial Hospital, Addis Ababa, Ethiopia.

Wotango B, Workneh W, Abdana T, Kidane H, Alemayehu M, Niku D BMJ Open Qual. 2025; 14(1).

PMID: 39961681 PMC: 11836857. DOI: 10.1136/bmjoq-2024-003058.

References

Fung M, Thebaud B . Stem cell-based therapy for neonatal lung disease: it is in the juice. Pediatr Res. 2013; 75(1-1):2-7. PMC: 3940470. DOI: 10.1038/pr.2013.176. View

Stevens T, Finer N, Carlo W, Szilagyi P, Phelps D, Walsh M . Respiratory outcomes of the surfactant positive pressure and oximetry randomized trial (SUPPORT). J Pediatr. 2014; 165(2):240-249.e4. PMC: 4111960. DOI: 10.1016/j.jpeds.2014.02.054. View

Vaucher Y, Peralta-Carcelen M, Finer N, Carlo W, Gantz M, Walsh M . Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012; 367(26):2495-504. PMC: 4140695. DOI: 10.1056/NEJMoa1208506. View

Finer N, Carlo W, Walsh M, Rich W, Gantz M, Laptook A . Early CPAP versus surfactant in extremely preterm infants. N Engl J Med. 2010; 362(21):1970-9. PMC: 3071534. DOI: 10.1056/NEJMoa0911783. View

Onland W, De Laat M, Mol B, Offringa M . Effects of antenatal corticosteroids given prior to 26 weeks' gestation: a systematic review of randomized controlled trials. Am J Perinatol. 2010; 28(1):33-44. DOI: 10.1055/s-0030-1262509. View

Stoll B, Hansen N, Bell E, Walsh M, Carlo W, Shankaran S . Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. JAMA. 2015; 314(10):1039-51. PMC: 4787615. DOI: 10.1001/jama.2015.10244. View

Avery G, Fletcher A, Kaplan M, Brudno D . Controlled trial of dexamethasone in respirator-dependent infants with bronchopulmonary dysplasia. Pediatrics. 1985; 75(1):106-11. View

Schmidt B, Roberts R, Davis P, Doyle L, Barrington K, Ohlsson A . Caffeine therapy for apnea of prematurity. N Engl J Med. 2006; 354(20):2112-21. DOI: 10.1056/NEJMoa054065. View

Philip A . Oxygen plus pressure plus time: the etiology of bronchopulmonary dysplasia. Pediatrics. 1975; 55(1):44-50. View

10.

McEvoy C, Spindel E . Pulmonary Effects of Maternal Smoking on the Fetus and Child: Effects on Lung Development, Respiratory Morbidities, and Life Long Lung Health. Paediatr Respir Rev. 2016; 21:27-33. PMC: 5303131. DOI: 10.1016/j.prrv.2016.08.005. View

11.

Keller R, Feng R, DeMauro S, Ferkol T, Hardie W, Rogers E . Bronchopulmonary Dysplasia and Perinatal Characteristics Predict 1-Year Respiratory Outcomes in Newborns Born at Extremely Low Gestational Age: A Prospective Cohort Study. J Pediatr. 2017; 187:89-97.e3. PMC: 5533632. DOI: 10.1016/j.jpeds.2017.04.026. View

12.

Abman S, Collaco J, Shepherd E, Keszler M, Cuevas-Guaman M, Welty S . Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia. J Pediatr. 2016; 181:12-28.e1. PMC: 5562402. DOI: 10.1016/j.jpeds.2016.10.082. View

13.

Ambalavanan N, Tyson J, Kennedy K, Hansen N, Vohr B, Wright L . Vitamin A supplementation for extremely low birth weight infants: outcome at 18 to 22 months. Pediatrics. 2005; 115(3):e249-54. DOI: 10.1542/peds.2004-1812. View

14.

Peacock J, Lo J, DCosta W, Calvert S, Marlow N, Greenough A . Respiratory morbidity at follow-up of small-for-gestational-age infants born very prematurely. Pediatr Res. 2012; 73(4 Pt 1):457-63. DOI: 10.1038/pr.2012.201. View

15.

Shennan A, Dunn M, Ohlsson A, Lennox K, Hoskins E . Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics. 1988; 82(4):527-32. View

16.

Baud O, Maury L, Lebail F, Ramful D, El Moussawi F, Nicaise C . Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet. 2016; 387(10030):1827-36. DOI: 10.1016/S0140-6736(16)00202-6. View

17.

Poindexter B, Feng R, Schmidt B, Aschner J, Ballard R, Hamvas A . Comparisons and Limitations of Current Definitions of Bronchopulmonary Dysplasia for the Prematurity and Respiratory Outcomes Program. Ann Am Thorac Soc. 2015; 12(12):1822-30. PMC: 4722827. DOI: 10.1513/AnnalsATS.201504-218OC. View

18.

Tarnow-Mordi W, Stenson B, Kirby A, Juszczak E, Donoghoe M, Deshpande S . Outcomes of Two Trials of Oxygen-Saturation Targets in Preterm Infants. N Engl J Med. 2016; 374(8):749-60. DOI: 10.1056/NEJMoa1514212. View

19.

NORTHWAY Jr W, ROSAN R, Porter D . Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967; 276(7):357-68. DOI: 10.1056/NEJM196702162760701. View

20.

Mourani P, Sontag M, Younoszai A, Miller J, Kinsella J, Baker C . Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2014; 191(1):87-95. PMC: 4299632. DOI: 10.1164/rccm.201409-1594OC. View